Skip to search.
 TSX Down 0.04% TSX Ventures Down 0.04%

Athersys, Inc. (ATHX)

-NasdaqCM
2.88 Mar 31, 4:00PM EDT
Add to Portfolio
Prev Close:2.88
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:6.00
Beta:-0.14
Earnings Date:May 6 - May 11 (Est.)
Day's Range:N/A - N/A
52wk Range:1.08 - 3.50
Volume:0
Avg Vol (3m):1,223,640
Market Cap:231.08M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):142.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Mar-15) :-0.09
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. The company’s lead platform product, MultiStem cell therapy, an allogeneic stem cell product, which is in Phase... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback